Literature DB >> 22435040

Treatment with risperidone and venlafaxine of a patient with double-coded diagnosis of body dysmorphic disorder and delusional disorder somatic type.

P Goulia, Ch Mantas, Ioannis D Bassukas, Th Hyphantis.   

Abstract

Entities:  

Keywords:  antidepressants; antipsychotics; delusional disorder somatic type; dysmorphophobia

Year:  2011        PMID： 22435040      PMCID： PMC3306049     

Source DB:  PubMed          Journal:  Hippokratia        ISSN： 1108-4189            Impact factor:   0.471


× No keyword cloud information.
  4 in total

1.  Delusional versus nondelusional body dysmorphic disorder: clinical features and course of illness.

Authors:  K A Phillips; W Menard; M E Pagano; C Fay; R L Stout
Journal:  J Psychiatr Res       Date:  2005-10-17       Impact factor: 4.791

2.  Delusional disorder, somatic type treated with aripiprazole--mirtazapine combination.

Authors:  N P Dimopoulos; C I Mitsonis; V V Psarra
Journal:  J Psychopharmacol       Date:  2008-02-28       Impact factor: 4.153

3.  Extremely grotesque somatic delusions in a patient of delusional disorder and its response to risperidone treatment.

Authors:  Takaki Akahane; Hiroshi Hayashi; Haruyoshi Suzuki; Shinobu Kawakatsu; Koichi Otani
Journal:  Gen Hosp Psychiatry       Date:  2008-09-02       Impact factor: 3.238

4.  An open-label trial of venlafaxine in body dysmorphic disorder.

Authors:  Andrea Allen; Sallie Jo Hadley; Alicia Kaplan; Daphne Simeon; Jennifer Friedberg; Lauren Priday; Bryann R Baker; Jennifer L Greenberg; Eric Hollander
Journal:  CNS Spectr       Date:  2008-02       Impact factor: 3.790
  4 in total
  1 in total

Review 1.  Critical Review of the Use of Second-Generation Antipsychotics in Obsessive-Compulsive and Related Disorders.

Authors:  Dongmi Kim; Nicole L Ryba; Julie Kalabalik; Ligia Westrich
Journal:  Drugs R D       Date:  2018-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.